Telomir Pharmaceuticals (TELO) Operating Expenses (2023 - 2026)
Telomir Pharmaceuticals (TELO) posted Operating Expenses of $2.1 million for Q4 2025, up 86.2% sequentially from $1.1 million in Q3 2025, and down 26.53% YoY from $2.9 million in Q4 2024.
Telomir Pharmaceuticals (TELO) Operating Expenses (2023 - 2026) Analysis & Trends
Telomir Pharmaceuticals has reported Operating Expenses for 3 years, with the latest figure at $2.1 million in Q4 2025.
- Quarterly Operating Expenses fell 26.53% year-over-year to $2.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.5 million (down 14.33% YoY) and the FY2025 annual result came in at $10.5 million, down 13.91% from the prior year.
- Operating Expenses rose to $2.1 million in Q4 2025 per TELO's latest filing, from $1.1 million in the prior quarter.
- Over five years, Operating Expenses peaked at $6.0 million in Q3 2024 and troughed at $482938.0 in Q1 2023.
- A 3-year average of $2.2 million and a median of $1.7 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2024 and 2025: Operating Expenses jumped 529.48% in 2024, then slumped 80.91% in 2025.
- Over 3 years, Operating Expenses stood at $1.1 million in 2023, then surged by 169.36% to $2.9 million in 2024, then dropped by 26.53% to $2.1 million in 2025.
- According to Business Quant data, Operating Expenses over the past three periods registered $2.1 million, $1.1 million, and $5.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Telomir Pharmaceuticals | 68.14 Mn | 68.14 Mn | - | 1.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.76 Mn |
| Dec 31, 2025 | 2.13 Mn |
| Sep 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 5.07 Mn |
| Mar 31, 2025 | 2.19 Mn |
| Dec 31, 2024 | 2.91 Mn |
| Sep 30, 2024 | 6.01 Mn |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | 1.92 Mn |
| Dec 31, 2023 | 1.08 Mn |
| Sep 30, 2023 | 954,153.00 |
| Jun 30, 2023 | 1.43 Mn |
| Mar 31, 2023 | 482,938.00 |